|
Moya-Quiles MR, Muro M. Characterisation of the Novel HLA-DQB1*03:571 Allele by Next-Generation Sequencing. HLA. 2025 Feb;105(2):e70048. doi: 10.1111/tan.70048. PubMed PMID: 39887651.
AÑO: 2025; IF: 5.9
|
39887651
|
Moya-Quiles MR, Muro M. Identification of the Novel HLA-A*01:478 Allele by Next-Generation Sequencing. HLA. 2025 Feb;105(2):e70045. doi: 10.1111/tan.70045. PubMed PMID: 39887659.
AÑO: 2025; IF: 5.9
|
|
Botella C, Galian JA, Jimenez-Coll V, Fernandez-Gonzalez M, Morales F, Martinez-Gomez G, Gonzalez-Lopez R, Alegria MJ, Moya MR, Martinez-Banaclocha H, Minguela A, Legaz I, Llorente S, Muro M. Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center. Life (Basel). 2024 Nov 16;14(11):1491. doi: 10.3390/life14111491. PubMed PMID: 39598289; PubMed Central PMCID: PMC11595986.
AÑO: 2024; IF: 3.2
|
|
Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos MJ, Galian JA, Botella C, Moya-Quiles R, Muro-Perez M, Minguela A, Llorente S, Muro M. MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. Biomedicines. 2024 Jan 5;12(1):116. doi: 10.3390/biomedicines12010116. PubMed PMID: 38255221; PubMed Central PMCID: PMC10813128.
AÑO: 2024; IF: 3.9
|
|
Moya-Quiles MR, Muro M. Identification of Two New HLA-DQA1 Alleles: HLA-DQA1*01:173 and -DQA1*03:82. HLA. 2024 Dec;104(6):e15802. doi: 10.1111/tan.15802. PubMed PMID: 39663905.
AÑO: 2024; IF: 5.9
|